Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - BNN Bloomberg
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
The Difficulties of Cloning a CEO - Bloomberg
Teva's Credit Rating Cut to Junk by Fitch - Bloomberg
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva's $15B free drug opioid settlement might be a great deal in the long run: analyst | Fierce Pharma
The Adderall supply squeeze in the US is growing
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Tags search | Ctech
Illinois eligible for portion of $4 billion Teva opioid settlement | Crain's Chicago Business
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Drugmaker Teva makes $40B bid for rival Mylan
New York jury holds drug firm Teva liable in opioid crisis
Teva Offers Drugs Valued at $23 Billion to End Opioid Suits - Bloomberg
Teva Pharmaceuticals Names Kare Schultz As New CEO | Fortune
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
Teva CEO to Meet Netanyahu With Blunt Message on Need for Cuts - Bloomberg
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
